Prakt. lékáren. 2015; 11(2): 68-70 [Urol. praxi, 2015; 16(2): 57-60]

Medicinal plants in prostatic problem treatment

Lenka Tůmová
Farmaceutická fakulta v Hradci Králové

The article describes medicinal plants and natural matters used in the treatment of prostatic complaints. Potentially effective medicinal

plants for these problems are also mentioned. The mechanism of their activity, side effects and notice on possible interactions with other

medication are also explained.

Keywords: prostate, Serenoa, Epilobium, Urtica, Pygeum africanum, silymarin, phytotherapy

Published: April 22, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tůmová L. Medicinal plants in prostatic problem treatment. Praktické lékárenství. 2015;11(2):68-70.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Poršová M, Kolombo I, Porš J., Kobzanová R, Pabišta R. Farmakoterapie benigní hyperplazie prostaty. Urol. praxi 2008; 9(5): 223-229.
    2. Hora M. Fytopreparáty v léčbě BHP. Urologické Listy 2004; 4: 42-45.
    3. Grančai D, Fialová S. Serenoa plazivá - Saw palmetto, lykopen a prhlava na prostatu. Léčivé rostliny 2011; 48(4): 146-148.
    4. Williamson E, Driver S, Baxter K. Stockley's Herbal Medicines Interactions, Pharmaceutical Press, UK, Second edition, 2013: 415-417.
    5. Mills S, Bone K. The Essential Guide to Herbal Safety, Elsevier Churchill Livingstone, Missouri, 2005: 560-562.
    6. Gordon AE. Saw palmetto for prostate disorders. American Family Physician 2003; 15(67): 1281-1283.
    7. Argirović A, Argirović D. Does the addition of Serenoa repens to tamsulosil improve its therapeurical efficiacy in begin prostatic hyperplasia. Vojnosanit Pregl 2013; 70(12): 1091-1096. Go to original source... Go to PubMed...
    8. Jahodář L. Farmakobotanika, semenné rostliny. Karolinum Praha 2006: 106.
    9. Shenouda SN, Sakla MS, Newton LG, Besh-Williford C, Greenberg. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Endocrine 2007; 31(1): 72-81. Go to original source... Go to PubMed...
    10. Elwekeel A, AbouZid S, Sokkar N, Elfishway A. Studies on flavonolignans from cultured cells of Silybum marianum. Acta Physiologiae. Plantarum 2012; 12: 1445-1449. Go to original source...
    11. Šimánek V, Kren V, Ulrichová J, Vicar J, Cvak L. Silymarin: What is in the name...? An appeal for a change of editorial policy. Hepatology 2000; 32(2): 442-444. Go to original source...
    12. Gazak R, Walterova D, Kren V. Silybin and Silymarin - New and Emerging Applications in Medicine. Curr Med Chem 2007; 14 (3): 315-33814.11. Go to original source... Go to PubMed...
    13. Avins AL, Lee JY, Meyers CM, Barry MJ. Safety and Toxicity of Saw Palmeto in the CAMUS Trial. Journal of Urology 2012; 189(4): 1415-1420. Go to original source... Go to PubMed...
    14. Tacklind J, MacDonald R, Rutks I, Stanke JU, Wilt TL. Serenoa repens for benign prostatic hyperplasia. Cochrane Summaries, published online 12 December 2012. Go to original source...
    15. Stolarczyk M, Piwowarski JP, Granica S, Stefanska J, Naruszewicz M, Kiss AK. Extracts from Epilobium sp Herbs, Their Components and Gut Microbial Metabolites of Epilobium Ellagitannins, Urolithins, Inhibit Hormone-Dependent prostate Cancer Cells-(LNCaP) Proliferation and PSA Secretion. Phytotherapy Research 2013; 27(12): 1842-1848. Go to original source... Go to PubMed...
    16. Witt TJ, Ishani A. Pygeum africanum for benign prostatic hyperplasia. The Cochrane Library (http://www.thecochranelibrary.com/view/0/inderx.html), online: 26 Jan 1998. Go to original source...
    17. Vyas BA, Desai NY, Patel PK. Effect of Boerhaavia diffusa in experimental prostatic hyperplasia in rats. Indian Journal of Pharmacology 2013; 45(3): 264-269. Go to original source... Go to PubMed...
    18. Wolfram J, Suri K, Huang Yi, Molinaro R, Borsoi C, Scott B, Boom K, Paolino D, Fresta M, Wang J, Ferrari M, Celia Ch. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells. Journal of Microencapsulation 2014; 31(5): 501-507. Go to original source... Go to PubMed...
    19. Wang Ch, Wan J, Mei Z, Yang X. Acridone alkaloids with cytotoxic and antimalarial activities from Zanthoxylum simulans Hance. Pharmacognosy Magazine 2014; 10(37): 73-76. Go to original source... Go to PubMed...
    20. de Lourdes Arruzazabala M, Molina V, Mas R, Shen H. Effects of D-004, a lipid extract from the royal palm (Roystonea regia) fruits, tamsulosin and their combined use on urodynamic changes induced with phenylephrine in rats. Arzneimittel-Forschung-Drug Research 2008; 58(2): 81-85. Go to original source...
    21. Buck AC, Cox R, Rees RWM, Ebeling L, John A. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with pollen extract, Cerniton: A double-blind placebo-controlled study. British Journal of Urology 1990; 66: 398-404. Go to original source... Go to PubMed...
    22. http://www.uroweb.org/guidelines/online/. Online: 5 Jan 2015.
    23. Hrušková M. Význam fytoterapie při léčbě benigní hyperplazie prostaty. Rigorózní práce, Farmaceutická fakulta UK v Hradci Králové, 2010.
    24. Kolombo I, Porš J, Poršová M, Poněšický J, Hain J, Gronka L, Blažej S, Kašík J, Pabišta R, Bartůněk M. Benigní hyperplazie prostaty, Urol. praxi 2008; 9(3): 140.
    25. Veselský Z, Macek P, Prošvic P, Rýdel L. Úloha fytoterapie v léčbě benigní hyperplazie prostaty. Urol. praxi 2001; 5: 201-203.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.